Form 4: Lemaitre Vascular Director Roberts Exercises Stock Options
SEC Form 4 Filing
Director David B. Roberts of Lemaitre Vascular, Inc. exercised stock options to acquire 2,818 shares of common stock at $35.48 per share on March 7, 2025.
Summary
- On March 7, 2025, David B. Roberts, a Director and President of Lemaitre Vascular, Inc., exercised stock options.
- He acquired 2,818 shares of common stock at a price of $35.48 per share.
- Following the transaction, Roberts directly owns 17,976 shares of Lemaitre Vascular, Inc.
- The exercised options were fully vested and exercisable since December 20, 2019, and expire on December 20, 2026.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The exercise of options could be seen as a slightly positive signal, but it's not a major event.
Positives
- The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the actions of company executives.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 12/20/2019 | Date the stock options became fully vested and exercisable |
| 03/07/2025 | Date of the transaction (exercise of stock options) |
| 03/11/2025 | Date of signature on the Form 4 filing |
| 12/20/2026 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.